Development of a first in class inhibitor of BET bromodomains and dopamine receptor 2

被引：0
|
作者：
Yoshioka, Makoto
Chauhan, Jay
Fletcher, Steven
Strovel, Jeffrey W.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-5062
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5062
引用
收藏
页数：1
相关论文
共 50 条
  • [1] RVX-297-a novel BD2 selective inhibitor of BET bromodomains
    Kharenko, Olesya A.
    Gesner, Emily M.
    Patel, Reena G.
    Norek, Karen
    White, Andre
    Fontano, Eric
    Suto, Robert K.
    Young, Peter R.
    McLure, Kevin G.
    Hansen, Henrik C.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 477 (01) : 62 - 67
  • [2] Bromodomains: a new target class for drug development
    Cochran, Andrea G.
    Conery, Andrew R.
    Sims, Robert J., III
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (08) : 609 - 628
  • [3] Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
    Mirguet, Olivier
    Gosmini, Romain
    Toum, Jerome
    Clement, Catherine A.
    Barnathan, Melanie
    Brusq, Jean-Marie
    Mordaunt, Jacqueline E.
    Grimes, Richard M.
    Crowe, Miriam
    Pineau, Olivier
    Ajakane, Myriam
    Daugan, Alain
    Jeffrey, Phillip
    Cutler, Leanne
    Haynes, Andrea C.
    Smithers, Nicholas N.
    Chung, Chun-wa
    Bamborough, Paul
    Uings, Iain J.
    Lewis, Antonia
    Witherington, Jason
    Parr, Nigel
    Prinjha, Rab K.
    Nicodeme, Edwige
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (19) : 7501 - 7515
  • [4] Bromodomains: a new target class for drug development
    Andrea G. Cochran
    Andrew R. Conery
    Robert J. Sims
    Nature Reviews Drug Discovery, 2019, 18 : 609 - 628
  • [5] GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins
    Watson, Robert J.
    Bamborough, Paul
    Barnett, Heather
    Chung, Chun-wa
    Davis, Rob
    Gordon, Laurie
    Grandi, Paola
    Petretich, Massimo
    Phillipou, Alex
    Prinjha, Rab K.
    Rioja, Inmaculada
    Soden, Peter
    Werner, Thilo
    Demont, Emmanuel H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (17) : 9045 - 9069
  • [6] PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains
    Picaud, Sarah
    Da Costa, David
    Thanasopoulou, Angeliki
    Filippakopoulos, Panagis
    Fish, Paul V.
    Philpott, Martin
    Fedorov, Oleg
    Brennan, Paul
    Bunnage, Mark E.
    Owen, Dafydd R.
    Bradner, James E.
    Taniere, Philippe
    O'Sullivan, Brendan
    Mueller, Susanne
    Schwaller, Juerg
    Stankovic, Tatjana
    Knapp, Stefan
    CANCER RESEARCH, 2013, 73 (11) : 3336 - 3346
  • [7] Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteins
    Chen, Deheng
    Lu, Tian
    Yan, Ziqin
    Lu, Wenchao
    Lyu, Xilin
    Xu, Biling
    Jiang, Hualiang
    Chen, Kaixian
    Luo, Cheng
    Zhao, Yujun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 182
  • [8] The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains
    Dittmann, Antje
    Werner, Thilo
    Chung, Chun-Wa
    Savitski, Mikhail M.
    Savitski, Maria Faelth
    Grandi, Paola
    Hopf, Carsten
    Lindon, Matthew
    Neubauer, Gitte
    Prinjha, Rabinder K.
    Bantscheff, Marcus
    Drewes, Gerard
    ACS CHEMICAL BIOLOGY, 2014, 9 (02) : 495 - 502
  • [9] GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family
    Preston, Alex
    Atkinson, Stephen J.
    Bamborough, Paul
    Chung, Chun-wa
    Gordon, Laurie J.
    Grandi, Paola
    Gray, James R. J.
    Harrison, Lee A.
    Lewis, Antonia J.
    Lugo, David
    Messenger, Cassie
    Michon, Anne-Marie
    Mitchell, Darren J.
    Prinjha, Rab K.
    Rioja, Inmaculada
    Seal, Jon
    Taylor, Simon
    Thesmar, Pierre
    Wall, Ian D.
    Watson, J.
    Woolven, James M.
    Demont, Emmanuel H.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (08): : 1581 - 1587
  • [10] A Novel Inhibitor of BET Family Bromodomains Demonstrates In Vivo and In Vitro Potency in B-Cell Malignancies
    El-Gamal, Dalia
    Hing, Zachary A.
    Mitchell, Shaneice
    LaFollette, Taylor D.
    Brennan, Paul J.
    Flynn, Joseph M.
    Jones, Jeffrey A.
    Awan, Farrukh
    Andritsos, Leslie A.
    Blachly, James S.
    Williams, Katie
    Harrington, Bonnie K.
    Goettl, Virginia M.
    Woyach, Jennifer A.
    Lehman, Amy M.
    Yu, Lianbo
    Byrd, John C.
    Lapalombella, Rosa
    BLOOD, 2015, 126 (23)
12345